Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-10-020437
Filing Date
2010-04-06
Accepted
2010-04-06 11:27:41
Documents
2
Period of Report
2010-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 - T. HOWSON rrd272171.html 3  
1 FORM 3 - T. HOWSON rrd272171.xml 3 1459
2 POWER OF ATTORNEY rrd243789_275178.htm EX-24.1 3221
  Complete submission text file 0001181431-10-020437.txt   6324
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
HOWSON TAMAR D (Reporting) CIK: 0001202286 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21990 | Film No.: 10733517